VistaGen Therapeutics logo
VistaGen Therapeutics VTGN
$ 0.16 -15.79%
report update icon

Quarterly report 2027-Q2
added 11-13-2026

VistaGen Therapeutics Total Non Current Liabilities | VTGN

Annual Total Non Current Liabilities VistaGen Therapeutics

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999
249 K 1.34 M 4.24 M 4.44 M 4.16 M 12.1 M 8.73 M 4.14 M 2.9 M 1.73 M 2.17 M 3.42 M 7.86 M 11 M 2.87 M 7.85 M - - - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
12.1 M 249 K 4.95 M

Quarterly Total Non Current Liabilities VistaGen Therapeutics

2027-Q1 2026-Q4 2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
63 K 249 K 607 K 946 K 1 M 1.34 M 1.56 M 2 M 2.51 M 4.24 M 3.62 M 3.64 M 4.13 M 4.44 M 3.64 M 4.13 M 4.44 M 4.16 M 4.75 M 3.75 M 3.75 M 4.14 M 11.9 M 12 M 12 M 12.5 M 12.7 M 9.11 M 8.01 M 8.49 M 8.25 M 8.01 M 4.14 M 2.9 M 2.65 M 3.16 M 2.04 M 1.73 M 2.4 M 2.04 M 1.73 M 2.17 M 1.14 M 1.14 M 994 K 3.42 M 909 K 1.33 M 3.42 M 7.86 M 10.9 M 9.96 M 9.96 M 8.29 M 8.29 M 9.91 M 9.45 M 7.86 M 3.94 M 2.54 M 2.54 M 11 M 3.07 M 3.21 M 3.21 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
12.7 M 63 K 4.85 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Non Current Liabilities Price % 24h Market Cap Country
Vanda Pharmaceuticals Vanda Pharmaceuticals
VNDA
16.6 M $ 3.44 -6.27 % $ 203 M usaUSA
Voyager Therapeutics Voyager Therapeutics
VYGR
29.7 M $ 1.52 -5.9 % $ 89.2 M usaUSA
Verrica Pharmaceuticals Verrica Pharmaceuticals
VRCA
5.95 M $ 2.74 -5.03 % $ 29.2 M usaUSA
Wave Life Sciences Ltd. Wave Life Sciences Ltd.
WVE
17.2 M $ 2.56 -6.07 % $ 432 M singaporeSingapore
XBiotech XBiotech
XBIT
1.8 M $ 1.75 4.17 % $ 53.4 M usaUSA
XTL Biopharmaceuticals Ltd. XTL Biopharmaceuticals Ltd.
XTLB
908 K $ 1.37 -7.43 % $ 922 M israelIsrael
Adial Pharmaceuticals Adial Pharmaceuticals
ADIL
665 K $ 3.15 -35.42 % $ 2.11 M usaUSA
ADMA Biologics ADMA Biologics
ADMA
77.4 M $ 13.18 -1.2 % $ 3.14 B usaUSA
Exicure Exicure
XCUR
25.2 M $ 0.96 -7.24 % $ 6.05 M usaUSA
Xencor Xencor
XNCR
144 M $ 33.48 -1.56 % $ 2.49 B usaUSA
Cortexyme Cortexyme
CRTX
86 M - -1.05 % $ 67.1 M usaUSA
Daré Bioscience Daré Bioscience
DARE
5.95 M $ 0.41 -9.93 % $ 4.58 M usaUSA
Fate Therapeutics Fate Therapeutics
FATE
29.7 M $ 0.92 -9.07 % $ 109 M usaUSA
Greenwich LifeSciences Greenwich LifeSciences
GLSI
9.5 M $ 19.09 -3.54 % $ 258 M usaUSA
Halozyme Therapeutics Halozyme Therapeutics
HALO
2.3 B $ 91.28 -1.89 % $ 10.9 B usaUSA
Hutchison China MediTech Limited Hutchison China MediTech Limited
HCM
186 M $ 13.18 -2.04 % $ 11.3 B chinaChina
Aptorum Group Limited Aptorum Group Limited
APM
306 K - - $ 5.72 M chinaChina
iBio iBio
IBIO
1.65 M $ 0.83 3.01 % $ 86.4 M usaUSA
Kodiak Sciences Kodiak Sciences
KOD
149 M $ 97.05 -0.87 % $ 5.16 B usaUSA
Karyopharm Therapeutics Karyopharm Therapeutics
KPTI
199 M $ 0.02 -56.5 % $ 219 usaUSA
FSD Pharma FSD Pharma
HUGE
79.1 K - 5743.5 % $ 69.7 M canadaCanada
BioAtla BioAtla
BCAB
24.7 M $ 1.74 0.64 % $ 102 M usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
2.56 M - - $ 3.85 B usaUSA
UroGen Pharma Ltd. UroGen Pharma Ltd.
URGN
260 M $ 28.91 -8.89 % $ 1.39 B israelIsrael
Catalyst Biosciences Catalyst Biosciences
CBIO
981 K $ 13.01 0.74 % $ 1.16 B usaUSA
ARCA biopharma ARCA biopharma
ABIO
1.31 M - 1052.0 % $ 415 M usaUSA
ADiTx Therapeutics ADiTx Therapeutics
ADTX
343 K - - $ 374 usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
14 M - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
3.42 M - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
3.86 M - - $ 1.01 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.49 M - 1.93 % $ 17.4 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
1.06 M - 10.36 % $ 9.8 M usaUSA
AlloVir AlloVir
ALVR
33.2 M - 4.14 % $ 49.1 M usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
382 M - - $ 5.18 B usaUSA
Athira Pharma Athira Pharma
ATHA
16.9 M - - $ 269 M usaUSA
AVROBIO AVROBIO
AVRO
43 K - 1083.1 % $ 745 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
34.7 B - - $ 96.9 B britainBritain
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
618 K - -2.5 % $ 5.88 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
2 B - 0.49 % $ 251 B cayman-islandsCayman-islands
EyePoint Pharmaceuticals EyePoint Pharmaceuticals
EYPT
20.9 M $ 0.23 -12.11 % $ 16.8 K usaUSA
Bio-Path Holdings Bio-Path Holdings
BPTH
434 K - - $ 100 K usaUSA
Cara Therapeutics Cara Therapeutics
CARA
85 K - -3.03 % $ 260 M usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
9.95 M - -0.88 % $ 598 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
72 K - -16.75 % $ 25.8 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
2 K - -5.98 % $ 34.1 M usaUSA
Diffusion Pharmaceuticals Diffusion Pharmaceuticals
DFFN
480 K - 11.68 % $ 8.97 M usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
5.24 M - -5.68 % $ 8.28 M usaUSA
Enochian Biosciences Enochian Biosciences
ENOB
56.2 K - - $ 40.5 M usaUSA